促结缔组织增生性小圆细胞肿瘤的基因组学揭示了与 DNA 损伤反应、上皮-间充质转化和免疫反应相关的基因失调。
The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response.
机构信息
Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 2133, Milan, Italy.
Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133, Milan, Italy.
出版信息
Cancer Commun (Lond). 2018 Nov 28;38(1):70. doi: 10.1186/s40880-018-0339-3.
BACKGROUND
Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive, and poorly investigated simple sarcoma with a low frequency of genetic deregulation other than an Ewing sarcoma RNA binding protein 1 (EWSR1)-Wilm's tumor suppressor (WT1) translocation. We used whole-exome sequencing to interrogate six consecutive pre-treated DSRCTs whose gene expression was previously investigated.
METHODS
DNA libraries were prepared from formalin-fixed, paraffin-embedded archival tissue specimens following the Agilent SureSelectXT2 target enrichment protocol and sequenced on Illumina NextSeq 500. Raw sequence data were aligned to the reference genome with Burrows-Wheeler Aligner algorithm. Somatic mutations and copy number alterations (CNAs) were identified using MuTect2 and EXCAVATOR2, respectively. Biological functions associated with altered genes were investigated through Ingenuity Pathway Analysis (IPA) software.
RESULTS
A total of 137 unique somatic mutations were identified: 133 mutated genes were case-specific, and 2 were mutated in two cases but in different positions. Among the 135 mutated genes, 27% were related to two biological categories: DNA damage-response (DDR) network that was also identified through IPA and mesenchymal-epithelial reverse transition (MErT)/epithelial-mesenchymal transition (EMT) already demonstrated to be relevant in DSRCT. The mutated genes in the DDR network were involved in various steps of transcription and particularly affected pre-mRNA. Half of these genes encoded RNA-binding proteins or DNA/RNA-binding proteins, which were recently recognized as a new class of DDR players. CNAs in genes/gene families, involved in MErT/EMT and DDR, were recurrent across patients and mostly segregated in the MErT/EMT category. In addition, recurrent gains of regions in chromosome 1 involving many MErT/EMT gene families and loss of one arm or the entire chromosome 6 affecting relevant immune-regulatory genes were recorded.
CONCLUSIONS
The emerging picture is an extreme inter-tumor heterogeneity, characterized by the concurrent deregulation of the DDR and MErT/EMT dynamic and plastic programs that could favour genomic instability and explain the refractory DSRCT profile.
背景
促结缔组织增生性小圆细胞肿瘤(DSRCT)是一种罕见的侵袭性、研究不足的单纯肉瘤,除了尤文肉瘤 RNA 结合蛋白 1(EWSR1)-Wilms 肿瘤抑制因子(WT1)易位外,其遗传失调的频率较低。我们使用全外显子组测序来检测六个连续的预处理 DSRCT,这些肿瘤的基因表达之前已经进行了研究。
方法
从福尔马林固定、石蜡包埋的存档组织标本中制备 DNA 文库,采用 Agilent SureSelectXT2 目标富集方案,在 Illumina NextSeq 500 上进行测序。使用 Burrows-Wheeler Aligner 算法将原始序列数据与参考基因组进行比对。使用 MuTect2 和 EXCAVATOR2 分别鉴定体细胞突变和拷贝数改变(CNA)。通过 IPA 软件(Ingenuity Pathway Analysis)研究与改变的基因相关的生物学功能。
结果
共鉴定出 137 个独特的体细胞突变:133 个突变基因是病例特异性的,有 2 个基因在两个病例中突变,但位置不同。在 135 个突变基因中,27%与两个生物学类别有关:DNA 损伤反应(DDR)网络,IPA 也鉴定出了这一网络,而间质-上皮逆转转化(MErT)/上皮-间质转化(EMT)已经被证明与 DSRCT 相关。DDR 网络中的突变基因参与了转录的各个步骤,特别是影响了前体 RNA。这些基因编码 RNA 结合蛋白或 DNA/RNA 结合蛋白的一半,这些蛋白最近被认为是 DDR 的一个新类别。涉及 MErT/EMT 和 DDR 的基因/基因家族的 CNA 在患者中反复出现,且大多聚集在 MErT/EMT 类别中。此外,还记录了染色体 1 上多个 MErT/EMT 基因家族的重复获得和一条或整个染色体 6 的缺失,影响了相关的免疫调节基因。
结论
新兴的情况是极度的肿瘤间异质性,其特征是 DDR 和 MErT/EMT 动态和可塑性程序的同时失调,这可能促进基因组不稳定性,并解释了 DSRCT 的难治性特征。